Yikuphi Okuhle Kakhulu Imithi Engafuni Ukwelapha?
Iziguli eziningi zichazwe imishanguzo yokulwa ne-nonsteroidal anti-inflammatory (evame ukubizwa ngokuthi i-NSAID) ngezimo ezihlukahlukene zomuthi we-orthopedic ezihlanganisa i- arthritis , i- tendonitis , ne- bursitis . Lezi mithi ziwusizo ikakhulukazi ngoba zisiza ukunciphisa ubuhlungu, kodwa futhi zisiza ukulawula ukuvuvukala nokuvuvukala.
Kodwa-ke, njenganoma yimiphi imithi, kunezingozi zombili kanye nezinzuzo, futhi abantu kufanele baqaphele ngaphambi kokubuyela ebhodleleni ukubhekana nezimpawu zabo.
Nakuba imithi ingaba ukwelashwa okuphephile futhi okuphumelelayo kwalezi zimo zamathambo, kungase kube nokunye okuphephile kumuthi. Ngaphambi kokuqala noma yimiphi imithi, cocisana ngenzuzo kanye nogqozi nodokotela wakho, futhi njalo qiniseka ukuthi udokotela wakho oyinhloko uyazi noma yimiphi imithi emisha oyithathayo, ikakhulukazi uma uyithatha njalo.
I-NSAID ye-prescription engcono?
Ama-NSAID atholakalayo kokubili kwe-counter and the medication. Kubalulekile ukuqonda ukuthi nakuba kunemibono phakathi kwama-NSAID odokotela abangekho emthethweni nokungavunyelwe, lo mthelela awuwona ukuphulukiswa okungenzeka kwamabonakaliso. Iziguli eziningi zithola impendulo yazo engcono kakhulu kuma-NSAID angaphezu kwe-counter.
Akuzange kube khona isifundo esibonisa ukuthi ama-NSAID amasha (okuthiwa yi-COX-2 inhibitors), ama-NSAID kadokotela , noma ama-NSAID abiza kakhulu , aphatha ubuhlungu noma avuvule noma yikuphi okungcono kunezinye izidakamizwa ze-NSAID. Iningi locwaningo oluhlola imiphumela ye-NSAID lenziwe ngokusebenzisa ibuprofen engaphezu kwe-counter.
Yikuphi okumele uthathe?
Ngokuvamile iziguli zizobhekana nempendulo ehlukile ekwelapheni ngemithi ehlukile. Lokhu kungakho abanye imithi eye yasize izimpawu zakho ngenkathi abanye bengenayo impumelelo enkulu. Lokhu akuyona into engavamile, futhi kunzima ukubikezela ukuthi imiphi imithi izozuza kakhulu umuntu onikeziwe.
Indlela engcono yokuthola ukuthi iyiphi i-NSAID engcono kakhulu kuwe ukuzama okukhethwa kukho okuhlukile. Ngokuvamile udokotela uzakutusa enye i-NSAID, futhi uma ukutholakala okwanele kwezimpawu kungatholakali phakathi kwamasonto ambalwa okwelashwa, enye i-NSAID ingahlolwa.
Esinye sezizathu ezizwakalayo zokubheka ezinye zemishanguzo, imishanguzo kadokotela, njengeCelebrex noma i-Mobic, ukuthi lezi zingathathwa njengokungenani ngosuku noma izikhathi ezine ngosuku. Ngaphezu kwalokho, ama-inhibitors e-COX-2 acatshangwa ukuthi anezimpikiswano ezimbalwa esiswini esiswini. Ngenxa yokuthi kungenzeka ukuthi kuncishiswe ingozi yesisu, kungenzeka odokotela bazongcoma i-COX-2 inhibitors ngeziguli ezingase zibe nezingozi zokusuka noma izilonda zesisu .
Indlela Yokulawula Ukuvuvukala
Imithi akuyona kuphela isisombululo sokulawula ukuvuvukala nokungahambi kahle. Njengoba siqhubeka siyazi futhi sizwela imiphumela emibi yocala yimuphi umuthi, iziguli eziningi kanye nodokotela ngokufanayo banesithakazelo ezindleleni ezingekho ze-pharmacologic zokulawula ukuvuvukala. Kunezindlela eziningi abantu ababhekana ngazo ukuvuvukala. Abanye banokusekelwa kwesayensi kangcono kunezinye, kodwa iningi liphephile ukuzama.
Indawo enhle okuzoqala ngayo nge-RICE ukwelashwa kokuvuvukala okusho ukuthi: ukuphumula, iqhwa, ukucindezela, nokuphakama.
Ezinye zokwelapha ezingase zibe usizo zihlanganisa ukudla nokudla okunomsoco owenzayo, izifo zokwelapha ezindaweni ezibuhlungu, nemisebenzi esenzayo.
Indlela evame ukunganaki ukulawula ukuvuvukala engikubona ezigulini zami kuphumula. Lokhu akusho ukuthi ukuphumula okuvela kuma-athletics, kodwa lokhu kusho ukuthi kuvumela ukuthi inxenye yomuzi emele ukuphumula emisebenzini evamile engase ikhulise ukuvuvukala. Siphila impilo ematasa engase ingavumeli ukuphumula, kodwa ukungazinaki izibonakaliso zokuvuvukala kungase kwandise inkinga. Ngakho-ke, funa izindlela zokuphumula ingxenye yakho yegciwane elimele ukuvumela ukuvuvukala kuphephe futhi inqubo yokutakula ivuleke.
Imithombo:
Berger, RG "Izidakamizwa ezingavumelani nezidakamizwa ezingekho emthethweni: Ukwenza izinqumo ezifanele" J. Am. I-Acad. I-Ortho. Ukuhlinzwa, ngo-Okthoba 1994; 2: 255 - 260.